CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 7 of 48

Rheumatology (Oxford)

Briefs 241–280 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas

    Cross-sectional studySpondyloarthritis & PsA

  2. Rheumatology (Oxford)

    18F-fluorodeoxyglucose PET/CT uptake characteristics in immune checkpoint inhibitor-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumatica

    Cohort studyVasculitis & PMR

  3. Rheumatology (Oxford)

    Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR database

    Cohort studySystemic sclerosis

  4. Rheumatology (Oxford)

    SLE-DAS responder index: a novel outcome measure with high performance for physician and patient outcomes in anifrolumab phase 2–3 trials

    Meta-analysisLupus & APS

  5. Rheumatology (Oxford)

    Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series

    Cohort studySystemic sclerosis

  6. Rheumatology (Oxford)

    Antimalarial use and extra-renal damage accrual in lupus nephritis: a longitudinal cohort study

    Cohort studyLupus & APS

  7. Rheumatology (Oxford)

    Automated whole-blood detection of IFI27 and OAS1 mRNA for distinguishing active systemic lupus erythematosus

    Diagnostic or prognostic studyLupus & APS

  8. Rheumatology (Oxford)

    Development of a time-dependent prediction model for the risk of Pneumocystis jirovecii pneumonia in ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  9. Rheumatology (Oxford)

    Fibrotic disease co-occurrence and associated risk of subsequent organ failure: a nationwide matched cohort study

    Cohort study

  10. Rheumatology (Oxford)

    Premenstrual syndrome and inflammatory activity in adolescent familial Mediterranean fever

    Cross-sectional studyPediatric

  11. Rheumatology (Oxford)

    Real-world application of the international myositis assessment and clinical studies group guidelines on cancer risk stratification

    Cohort studyMyositis

  12. Rheumatology (Oxford)

    Cluster-defined gout subtypes exhibit divergent chronic kidney disease trajectories: a machine learning approach in a Chinese prospective cohort

    Cohort studyGout & crystals

  13. Rheumatology (Oxford)

    Diarrhoea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study

    Cohort study

  14. Rheumatology (Oxford)

    Menstruation in adolescents with familial Mediterranean fever: attack trigger or dysmenorrhoea? A prospective cross-sectional study

    Cross-sectional studyPediatric

  15. Rheumatology (Oxford)

    Factors associated with anakinra effectiveness and risk of infection in crystal-related flares

    Cohort studyGout & crystals

  16. Rheumatology (Oxford)

    Assessment of the use of biologic drugs in the treatment of primary antiphospholipid syndrome

    Meta-analysisLupus & APS

  17. Rheumatology (Oxford)

    Clinical, serological and haemodynamic factors associated with poor outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension: a multicentre retrospective study from Korea

    Cohort studyLupus & APS

  18. Rheumatology (Oxford)

    Humoral responses against high-density lipoprotein are linked to unfavourable lipid and proteomic signatures in primary Sjögren’s disease—a multi-platform approach

    Cross-sectional study

  19. Rheumatology (Oxford)

    Incremental value of carotid intima-media thickness beyond SCORE2 in identifying subclinical atherosclerosis in PsA

    Cross-sectional studySpondyloarthritis & PsA

  20. Rheumatology (Oxford)

    Coping with rheumatic stressors in long-standing axial spondyloarthritis: association with patient and disease characteristics

    Cohort studySpondyloarthritis & PsA

  21. Rheumatology (Oxford)

    Cumulative defined daily doses enable objective assessment of treatment intensity and outcome prediction in immunoglobulin G4-related disease and its subtypes

    Cohort studyAutoinflammatory & rare

  22. Rheumatology (Oxford)

    Urological manifestations in familial Mediterranean fever excluding renal amyloidosis: a systematic review

    Meta-analysisAutoinflammatory & rare

  23. Rheumatology (Oxford)

    Application of a novel Musculoskeletal Ultrasound Sum Score (MUSS) in the follow-up of patients with juvenile idiopathic arthritis

    Cohort studyPediatric

  24. Rheumatology (Oxford)

    Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies

    Cohort studyMyositis

  25. Rheumatology (Oxford)

    Exploring sleep health and circadian rhythm disruption in Sjögren’s disease: an accelerometric and self-reported cross-sectional study

    Cross-sectional studySjögren's & overlap

  26. Rheumatology (Oxford)

    Central pain sensitivity is associated with changes in fatigue in RA: data from the CAP-RA study

    Cohort studyRA

  27. Rheumatology (Oxford)

    Rheumatologist assessment in established polymyalgia rheumatica

    Cohort studyVasculitis & PMR

  28. Rheumatology (Oxford)

    Sex-based differences in bDMARD initiation and persistence in spondyloarthritis: a 17-year follow-up study from the REGISPON-3 registry

    Cohort studySpondyloarthritis & PsA

  29. Rheumatology (Oxford)

    Treatment satisfaction, disease severity, and health-care use in patients with axial spondyloarthritis in the United States and Europe

    Cross-sectional studySpondyloarthritis & PsA

  30. Rheumatology (Oxford)

    Incident rheumatoid arthritis and work loss: a nationwide sibling comparison study

    Cohort studyRA

  31. Rheumatology (Oxford)

    Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies

    Randomized controlled trialSpondyloarthritis & PsA

  32. Rheumatology (Oxford)

    Nailfold capillaroscopy improves cardiovascular risk stratification in SSc: an adjustment of the SCORE2 algorithm

    Cohort studySystemic sclerosis

  33. Rheumatology (Oxford)

    The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosus

    Cohort studyLupus & APS

  34. Rheumatology (Oxford)

    B-cell monitoring predicts infection risk in childhood SLE patients on belimumab

    Cohort studyPediatric

  35. Rheumatology (Oxford)

    Segmental spinal damage predicts mobility restriction and functional decline in radiographic axial spondyloarthritis: a longitudinal study

    Cohort studySpondyloarthritis & PsA

  36. Rheumatology (Oxford)

    Time and patient journey to axial spondyloarthritis diagnosis: a retrospective study in French primary care

    Cohort studySpondyloarthritis & PsA

  37. Rheumatology (Oxford)

    Vaccination rates in rheumatic diseases: a cross-sectional register study on the role of patient beliefs and physician engagement

    Cross-sectional studyAcross diseases

  38. Rheumatology (Oxford)

    Renal outcomes in ANCA-associated vasculitis without clinically apparent kidney involvement: a multicentre REVEAL cohort study

    Cohort studyVasculitis & PMR

  39. Rheumatology (Oxford)

    Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis

    Cross-sectional studySpondyloarthritis & PsA

  40. Rheumatology (Oxford)

    Association between anti-synthetase syndrome and malignancy: a systematic review and meta-analysis

    Meta-analysisMyositis

All 1,905 Briefs in ExploreShowing Briefs 241–280 of 1,905, newest first